Analysis of PDMP Data Assessing Impact of State Intervention on High-Risk Prescri

项目总结/摘要 我们希望开发一种廉价的、以州为基础的干预措施，以减少错误的处方， 鼓励更谨慎的处方做法。纽约州处方药监测数据库 （PAPK）将用于识别处方过高剂量阿片类药物的临床医生 镇痛剂和/或经常处方阿片类药物与苯二氮卓类药物的组合。这些 临床医生将收到来自纽约州卫生部的邮件， 他告诉他们，他们的处方模式引起了对病人安全的担忧。这 邮件将包括关于阿片类药物处方的简短教育材料， 减少危险的处方做法。 将分析误开处方者的处方模式。对比六个月前的 干预处方模式到六个月的干预后处方模式将使我们能够 评估干预的结果。如果干预有效，其他拥有PDMP的州可能希望 复制该计划，以减少阿片类药物相关的过量死亡。

Project Summary/Abstract We wish to develop an inexpensive, state-based intervention to reduce mis-prescribing and to foster more cautious prescribing practices. The New York State Prescription Drug Monitoring Databse (PDMP) will be utilized to identify clinicians who are prescribing excessively high doses of opioid analgesics and/or are frequently prescribing opioids in combination with benzodiazepines. These clinicians will receive a mailing from the New York State Department of Health, which oversees the PDMP, informing them that their prescribing patterns have raised concerns about patient safety. This mailing will include brief educational materials on opioid prescribing that focus specifically on decreasing dangerous prescribing practices. Prescribing patterns for misprescribers will be analyzed. Comparing six months of pre- intervention prescribing patterns to six months of post-intervention prescribing patterns will allow us to assess outcomes of the intervention. If the intervention is effective, other states with PDMPs may wish to replicate the program to reduce opioid-related overdose deaths.